Literature DB >> 12851569

Erythromycin ototoxicity.

Lee J McGhan1, Saumil N Merchant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12851569     DOI： 10.1097/00129492-200307000-00029

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN： 1531-7129            Impact factor:   2.311


× No keyword cloud information.
  4 in total

Review 1.  Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.

Authors:  P Zarogoulidis; N Papanas; I Kioumis; E Chatzaki; E Maltezos; K Zarogoulidis
Journal:  Eur J Clin Pharmacol       Date:  2011-11-22       Impact factor: 2.953

Review 2.  Ototoxicity of Non-aminoglycoside Antibiotics.

Authors:  Leonard P Rybak; Vickram Ramkumar; Debashree Mukherjea
Journal:  Front Neurol       Date:  2021-03-09       Impact factor: 4.003

3.  Time-controllable Nkcc1 knockdown replicates reversible hearing loss in postnatal mice.

Authors:  Takahisa Watabe; Ming Xu; Miho Watanabe; Junichi Nabekura; Taiga Higuchi; Karin Hori; Mitsuo P Sato; Fumiaki Nin; Hiroshi Hibino; Kaoru Ogawa; Masatsugu Masuda; Kenji F Tanaka
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

4.  Macrolide-associated ototoxicity: a cross-sectional and longitudinal study to assess the association of macrolide use with tinnitus and hearing loss.

Authors:  Anna Vanoverschelde; Berthe C Oosterloo; Nelly F Ly; M Arfan Ikram; André Goedegebure; Bruno H Stricker; Lies Lahousse
Journal:  J Antimicrob Chemother       Date:  2021-09-15       Impact factor: 5.790
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.